Mycophenolate Mofetil and Fundus Autofluorescence in the Management of Recurrent Punctate Inner Choroidopathy

Basit Öğe Kaydı
dc.authoridturkcuoglu, peykan/0000-0002-9750-6213
dc.authoridSophie, Raafay/0000-0003-3207-9094
dc.authorwosidturkcuoglu, peykan/GQB-2596-2022
dc.authorwosidNguyen, Quan/JMP-5630-2023
dc.authorwosidwang, jian/GVS-0711-2022
dc.authorwosidC, Roomasa/AAK-5176-2020
dc.authorwosidC, R/HJA-9099-2022
dc.authorwosidIbrahim, Mohamed Fahmy/AAP-7467-2021
dc.authorwosidNguyen, Truong/JXN-9786-2024
dc.contributor.authorTurkcuoglu, Peykan
dc.contributor.authorChang, Peter Y.
dc.contributor.authorRentiya, Zubir S.
dc.contributor.authorChanna, Roomasa
dc.contributor.authorIbrahim, Mohamed
dc.contributor.authorHatef, Elham
dc.contributor.authorSophie, Raafay
dc.date.accessioned2024-08-04T20:32:55Z
dc.date.available2024-08-04T20:32:55Z
dc.date.issued2011
dc.departmentİnönü Üniversitesien_US
dc.description.abstractMethods: Eight patients who had at least two recurrent episodes of increased activity before MMF and 12 months of documented clinical course before and after MMF were included. The frequencies of attacks before and after MMF were compared. FAF images evaluated. Results: Before MMF, the 8 patients experienced 19 attacks of recurrent disease activity; during MMF therapy, 3 (38%) patients experienced 6 recurrent episodes. The attack frequencies were 1.09 +/-+/- 0.75 before and 0.23 +/-+/- 0.32 during treatment (p == .036). Among the 6 patients who had FAF, surrounding hyperautofluorescent halo was detected in 4 and recurrence occurred in 2 who did not show any changes on the intensity during treatment. Conclusion: In the index study, the employment of MMF has decreased frequency of attacks in recurrent PIC. FAF may be employed to monitor and predict the response to treatment.en_US
dc.identifier.doi10.3109/09273948.2011.580072
dc.identifier.endpage292en_US
dc.identifier.issn0927-3948
dc.identifier.issue4en_US
dc.identifier.pmid21770809en_US
dc.identifier.scopus2-s2.0-79960672974en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage286en_US
dc.identifier.urihttps://doi.org/10.3109/09273948.2011.580072
dc.identifier.urihttps://hdl.handle.net/11616/95389
dc.identifier.volume19en_US
dc.identifier.wosWOS:000292915300014en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherInforma Healthcareen_US
dc.relation.ispartofOcular Immunology and Inflammationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectInflammatory Eye Diseaseen_US
dc.subjectChoroidal Neovascularizationen_US
dc.subjectImmunosuppressive Agenten_US
dc.subjectUveitisen_US
dc.subjectTherapyen_US
dc.subjectResolutionen_US
dc.subjectDisordersen_US
dc.subjectScleritisen_US
dc.titleMycophenolate Mofetil and Fundus Autofluorescence in the Management of Recurrent Punctate Inner Choroidopathyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu